DIFFICULTIES IN THE LIBERALIZATION OF THE MARKET OF OTC MEDICATIONS IN REPUBLIC OF NORTH MACEDONIA AND EXPERIENCES FROM EUROPEAN COUNTRIES

Abstract

Amendments to the Law on Medicines and Medical Devices (Official Gazette 27/2014) allow the marketing of OTC drugs outside pharmacies. Despite numerous controversies among the concerned parties, in February 2014, the Ministry of Health announced a list of medicines that can be sold at certain points of sale, namely in supermarkets and gas stations, arguing that the sale of OTC medications outside pharmacies is a practice that has been implemented in several European countries and, in addition, the increased market competition will lead to lower prices for these medicines. Practically, the European countries share different views on this issue. In 10 out of the 28 European countries there is a monopoly in the pharmaceutical sector in terms of the sale of OTC medicines, whereas in the remaining 18 countries, OTC medicines can be sold outside pharmacies. In addition, the range of OTC medicines that can be sold outside pharmacies varies among different countries. In some countries, the list of medications that can be sold outside pharmacies is quite restricted. In the Republic of North Macedonia, this list includes 108 drugs. This approach in the sale of OTC drugs in Republic of North Macedonia has been viewed with a great deal of skepticism by pharmacists. Its implementation in practice remains a challenge for relevant institutions in the country.

Authors and Affiliations

Merita Dauti, Arlinda Hajxhiu-Zajmi, Edita Alili, Sihana Ahmeti Lika, Gjylai Alija

Keywords

Related Articles

STUDY ON THE IMPACT OF METFORMIN ON THE EFFECT OF PALM OIL IN THE METABOLISM OF CARBOHYDRATES

Introduction: Research has been published on the frequency of Metformin use in patients with various complications who have been using fat-rich foods. Our analysis of a large number of studies shows that: in parallel wit...

ESSENTIAL ARTERIAL HIPERTENSION (AHT) AND RENAL CHRONIC SUSPENSION

Arterial hypertension (AHT) is a high risk factor for patients with chronic renal failure. Over 72 million people are suffering from AHT in the US. AHT usually affects most patients with chronic renal disease (Nwankwo et...

THE ALTERATIONS OF THE ENZYMATIC ANTIOXYDANT ACTIVITY BY ADDING ALKALINE WATER ON THE WHITE LABORATORY RATS AFTER HYPERTHERMIC STRESS

Alkaline water is in the focus of scientific interest over the last decade, due to its ability to alkalize the organism as well as its antioxidant effect. Due the hyperthermia, systemic and cellular changes occurs. Addin...

EFFECT OF METHOTREXATE ON THE VALUES OF RHEUMATOID FACTOR AND LIPOPROTEIN (A) AND CORRELATIONS BETWEEN THEIR VALUES IN PATIENTS WITH RHEUMATOID ARTHRITIS

Objective: To examine the disease activity score, the values of Rheumatoid factor and Lipoprotein (a) in patients with active and untreated Rheumatoid Arthritis (RA) before and after treatment with Methotrexate (MTX). Ma...

LEFT VENTRICULAR HYPERTROPHY RISK FACTOR IN PATIENTS WITH END STAGE RENALE DISEASE TREATED WITH HAEMODIALYSIS

Cardiovascular diseases (CVD) are the main cause of morbidity and mortality in patients suffering from End- Stage Renal Disease (ESRD) and undergoing treatment by long-term haemodialysis. One of the complications for ure...

Download PDF file
  • EP ID EP655568
  • DOI -
  • Views 208
  • Downloads 0

How To Cite

Merita Dauti, Arlinda Hajxhiu-Zajmi, Edita Alili, Sihana Ahmeti Lika, Gjylai Alija (2019). DIFFICULTIES IN THE LIBERALIZATION OF THE MARKET OF OTC MEDICATIONS IN REPUBLIC OF NORTH MACEDONIA AND EXPERIENCES FROM EUROPEAN COUNTRIES. Acta Medica Balkanica - International Journal of Medical Sciences, 4(7), 86-90. https://europub.co.uk/articles/-A-655568